Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Esperion Therapeutics Inc (ESPR)

  7. Esperion Therapeutics Inc (ESPR) News

ESPR

Esperion Therapeutics Inc

1.33
0.00 (0.0%)
Upgrade to Real-Time
Company Name Stock Ticker Symbol Market Type
Esperion Therapeutics Inc ESPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.00 0.0% 1.33 19:21:32
Open Price Low Price High Price Close Price Prev Close
1.35 1.275 1.36 1.36 1.33
more quote information »

Recent News

Date Time Source Heading
6/01/202308:00GLOBEEsperion Announces Submission of Supplemental New Drug..
5/25/202316:30GLOBEEsperion Announces Adjournment of 2023 Annual Meeting of..
5/24/202308:00GLOBEEsperion to Participate in Jefferies Healthcare Conference
5/18/202316:10EDGARStatement of Changes in Beneficial Ownership (4)
5/17/202316:40EDGARReport of Proposed Sale of Securities (144)
5/12/202316:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
5/11/202316:11EDGARStatement of Changes in Beneficial Ownership (4)
5/10/202316:13EDGARStatement of Changes in Beneficial Ownership (4)
5/09/202309:01EDGARQuarterly Report (10-q)
5/09/202307:23EDGARCurrent Report Filing (8-k)
5/09/202307:00GLOBEEsperion Reports First Quarter 2023 Financial Results
5/04/202308:30GLOBEEsperion Retains Gibson Dunn to Secure $300 Million Payment..
5/01/202308:00GLOBEEsperion to Participate in JMP Securities Life Sciences..
4/27/202308:00GLOBEEsperion to Participate in Bank of America Securities 2023..
4/25/202308:00GLOBEEsperion to Report First Quarter 2023 Financial Results May..
4/20/202316:14EDGARStatement of Changes in Beneficial Ownership (4)
4/20/202316:12EDGARStatement of Changes in Beneficial Ownership (4)
4/19/202316:14EDGARAmended Report of Proposed Sale of Securities (144/a)
4/19/202315:39EDGARReport of Proposed Sale of Securities (144)
4/19/202315:25EDGARReport of Proposed Sale of Securities (144)
4/19/202315:23EDGARReport of Proposed Sale of Securities (144)
4/19/202308:42GLOBEEsperion Announces Co-Promotion Agreement With Currax..
4/13/202316:11EDGARProxy Statement (definitive) (def 14a)
4/03/202316:14EDGARProxy Statement - Notice of Shareholders Meeting..
4/03/202308:00GLOBEEsperion to Participate in Needham 22nd Annual Virtual..
3/22/202316:41EDGARCurrent Report Filing (8-k)
3/22/202316:36EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
3/22/202316:15GLOBEEsperion Announces Closing of $56.7 Million Registered..
3/21/202316:06EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/20/202316:20EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202316:17EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202316:17EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202308:00GLOBEEsperion Announces $56.7 Million Registered Direct Offering..
3/15/202316:27EDGARCurrent Report Filing (8-k)
3/15/202309:23EDGARStatement of Changes in Beneficial Ownership (4)
3/15/202309:23EDGARStatement of Changes in Beneficial Ownership (4)
3/10/202316:32EDGARCurrent Report Filing (8-k)
3/08/202316:23EDGARStatement of Changes in Beneficial Ownership (4)
3/08/202316:23EDGARStatement of Changes in Beneficial Ownership (4)
3/08/202316:22EDGARStatement of Changes in Beneficial Ownership (4)
3/08/202308:00GLOBEInternational Lipid Expert Panel (ILEP) Recommends Use of..
3/07/202315:32EDGARReport of Proposed Sale of Securities (144)
3/06/202309:47EDGARCurrent Report Filing (8-k)
3/04/202310:30GLOBELandmark CLEAR Outcomes Study Demonstrates NEXLETOL®..
2/24/202313:40GLOBEEsperion Launches New Scientific Website
2/23/202308:00GLOBEEsperion to Participate in the Cowen 43rd Annual Healthcare..
2/22/202308:00GLOBECLEAR Outcomes Company Update Call: Detailed Results..
2/21/202316:07EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/21/202309:26EDGARAnnual Report (10-k)
2/21/202307:00GLOBEEsperion Reports Fourth Quarter and Full Year 2022 Financial..